Hologic Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, Inc. - HOLX

Core Viewpoint - The proposed sale of Hologic, Inc. to funds managed by Blackstone and TPG is under investigation to assess whether the offered consideration adequately reflects the company's value [1]. Group 1: Transaction Details - Shareholders of Hologic will receive $76.00 per share in cash [1]. - In addition to the cash payment, shareholders will receive a non-tradable contingent value right to receive up to $3.00 per share, payable in two installments of up to $1.50 each [1]. Group 2: Legal Investigation - Kahn Swick & Foti, LLC is investigating the adequacy of the proposed transaction and the process leading to it [1]. - The firm is reaching out to shareholders who believe the transaction undervalues the company to discuss their legal rights [2].